Navigation Links
FDA Performs Inspection of Impax's Hayward Facility
Date:8/4/2014

ucts; the Company's ability to sustain profitability and positive cash flows; any delays or unanticipated expenses in connection with the operation of the Company's manufacturing facilities; the effect of foreign economic, political, legal, and other risks on the Company's operations abroad; the uncertainty of patent litigation and other legal proceedings; the increased government scrutiny on the Company's agreements with brand pharmaceutical companies; product development risks and the difficulty of predicting FDA filings and approvals; consumer acceptance and demand for new pharmaceutical products; the impact of market perceptions of the Company and the safety and quality of the Company's products; the Company's determinations to discontinue the manufacture and distribution of certain products; the Company's ability to achieve returns on its investments in research and development activities; the Company's inexperience in conducting clinical trials and submitting new drug applications; the Company's ability to successfully conduct clinical trials; the Company's reliance on third parties to conduct clinical trials and testing; the Company's lack of a license partner for commercialization of IPX066 outside of the United States; impact of illegal distribution and sale by third parties of counterfeits or stolen products; the availability of raw materials and impact of interruptions in the Company's supply chain; the Company's policies regarding returns, allowances and chargebacks; the use of controlled substances in the Company's products; the effect of current economic conditions on our industry, business, results of operations and financial condition; disruptions or failures in the Company's information technology systems and network infrastructure; the Company's reliance on alliance and collaboration agreements; the Company's reliance on licenses to proprietary technologies; the Company's dependence on certain employees; the Company's abil
'/>"/>
SOURCE Impax Laboratories, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patients Bedside In Less Than An Hour
2. UCLA Performs First Breathing Lung Transplant In United States
3. Breakthrough Research Could Create Sea Change in Global HIV Diagnosis: New Handheld Mobile Device Performs Laboratory-Quality HIV Testing
4. Only Podiatric Surgeon In S. Florida That Performs In-Office Ultrasound Imaging On Foot & Ankle Problems Saving Patients Over $1,000 In MRI Expenses & Extra Trip To Hospital
5. Molecular Imaging Services, Inc. Performs First Rubidium-82 Cardiac PET Scan In Delaware
6. Conroe Physician Performs Laser Tattoo Removal with Astanza Duality Technology at Vanishing Ink MD
7. Henry Ford Hospital Performs First Minimally Invasive Laser Brain Surgeries in Michigan
8. Harrisburg-based Cardiovascular Institute Performs First MitraClip Procedure in Pennsylvania
9. Keck Medicine of USC performs worlds 1st implant after FDA approval for groundbreaking epilepsy treatment
10. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
11. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 PharmaEngine, Inc. (TWO:4162) today announced ... MACK ) with its sublicensing partner, Baxter ... that Baxter has submitted a marketing authorization application ... MM-398 (irinotecan liposome injection), also known as "nal-IRI," ... who have been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... , May 4, 2015 Bayer HealthCare (Bayer) ... Pharmaceuticals, Inc. (NASDAQ: ISIS ) on ISIS-FXI Rx, ... the prevention of thrombosis. Under the agreement Bayer will ... of high unmet medical need. As part of the ... profile of ISIS-FXI Rx in an appropriate patient ...
(Date:5/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI Rx ... of the agreement, Isis is eligible to receive up ... $100 million up-front payment and a $55 million payment ... study in patients with compromised kidney function. Isis is ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... April 26, 2011 Cadence Pharmaceuticals, Inc. ... on in-licensing, developing and commercializing proprietary products principally for ... company,s President and CEO Theodore Schroeder will present a ... month of May: Deutsche Bank,s 36th ...
... Lilly and Company (NYSE: LLY ) and Medtronic, ... entered into a collaboration to research and develop a new ... new  medicine to the brain using an implantable drug delivery ... therapeutic approach for Parkinson,s disease that combines the strengths of ...
Cached Medicine Technology:Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease 2Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease 3
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, a result-driven ... and staff gather in the common room to celebrate ... to gain encouragement and inspiration in their continuing effort ... those patients who have completed their recovery programs come ... share a bit about their journey with the audience. ...
(Date:5/4/2015)... Global Vision, the industry leader ... announced that it will showcase Proofware at the ... in Nashville Tennessee, May 04 and May 05. ... all-in-one we-based packaging inspection suite, giving enterprise-wide instant ... their brand copy and artwork. Proofware offers a ...
(Date:5/4/2015)... MO (PRWEB) May 04, 2015 Leonardo ... president and chief physician executive, and William C. Daniel, ... received and accepted personal invitations from the Secretary of ... Security Forum (NSF) at the Air War College, Maxwell ... to expose influential citizens to senior U.S. and international ...
(Date:5/4/2015)... 2015 Milton Hershey School® has named ... of the Year, recognizing his commitment to pediatric cancer ... sets for MHS students. , “Dr. Graves is a ... children are provided a top-notch education, a nurturing environment, ... said Pete Gurt ’85, president of MHS. “He is ...
(Date:5/4/2015)... McNeil & Company , a nationwide ... coverage for its Emergency Services Insurance Program ... and proactive risk management to the emergency services industry. ... providing our customers with unparalleled service and the best ... are excited to launch over 100 new enhancements that ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3
... edition Mustang at the New York, International Auto Show to raise money for ... ... G. Komen Race for the Cure - to $500 ... dedicated more than $95 million in, cash and in-kind contributions for breast cancer education ...
... Placing a "super-long coffee order,",a quirky trait ... a,difference for Children,s Hospital and Regional Medical Center., ... $1 to Children,s,Hospital for every Tully,s Coffee customer ... unique concoctions made up of seemingly,incongruous ingredients and ...
... BETHESDA, Md., March 18 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: ... Board of,Directors has unanimously approved a three-for-two split of ... per share, including its Class,B Common Stock. Stockholders of ... 2008 will receive one-half additional share of Common Stock ...
... March 18 W. Scott Harkonen,M.D., the former ... fraud and,felony Food, Drug and Cosmetic Act charges ... false and misleading information about the efficacy of,InterMune,s ... pulmonary fibrosis (IPF), the Justice Department announced,today., ...
... Statement Is Contrary to Widely Held American Values, ... and CEO, Religious,Coalition for Reproductive Choice, WASHINGTON, ... the national coalition of mainstream religious and,religiously affiliated ... reproductive healthcare and for women themselves in,the statement ...
... 18 Leading experts and,distinguished faculty in ... protocols and research to over 400 multi-disciplinary,clinicians ... Disorders,Professionals Symposium (iaedp(TM)) ( http://www.iaedp.com/ ) April ... in Orlando, Florida., "This year,s symposium ...
Cached Medicine News:Health News:Ford Launches 'Warriors in Pink' Mustang for '09, Doubles Contributions To Race For The Cure 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 3Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 2Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 4Health News:National Religious Coalition Deeply Concerned by HHS Secretary's Disregard for Women's Reproductive Health 2Health News:Eating Disorders Take Center Stage at iaedp(TM) 2008 Symposium in Orlando, Florida 2
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
Medicine Products: